Diagnosis of leishmaniasis Kotb Abd Elghany Elmahallawy, Ehab Sampedro Martínez, Antonio Rodríguez Granger, Javier Hoyos Mallecot, Yannick Agil Abdalla, Mhmad Ahmad Navarro-Marí, José María Gutiérrez Fernández, José Leishmaniasis Diagnosis Serology HIV co-infection This work was supported by EK Elmahallawy, who has a PhD scholarship (number 736) from Erasmus Mundus Scholarship Programme (ELEMENT Action 1 First call). Leishmaniasis is a clinically heterogeneous syndrome caused by intracellular protozoan parasites of the genus Leishmania. The clinical spectrum of leishmaniasis encompasses subclinical ( not apparent), localized (skin lesion), and disseminated (cutaneous, mucocutaneous, and visceral) infection. This spectrum of manifestations depends on the immune status of the host, on the parasite, and on immunoinflammatory responses. Visceral leishmaniasis causes high morbidity and mortality in the developing world. Reliable laboratory methods become mandatory for accurate diagnosis, especially in immunocompromised patients such as those infected with HIV. In this article, we review the current state of the diagnostic tools for leishmaniasis, especially the serological test. 2020-07-28T11:04:53Z 2020-07-28T11:04:53Z 2014-08 journal article Elmahallawy, E. K., Martínez, A. S., Rodriguez-Granger, J., Hoyos-Mallecot, Y., Agil, A., Mari, J. M. N., & Fernández, J. G. (2014). Diagnosis of leishmaniasis. The Journal of Infection in Developing Countries, 8(08), 961-972. [doi:10.3855/jidc.4310] http://hdl.handle.net/10481/63166 10.3855/jidc.4310 eng http://creativecommons.org/licenses/by/3.0/es/ open access Atribución 3.0 España The Journal of Infection in Developing Countries